Effect of omega-3 and vitamin e supplementation on dry mouth in patients with Sjögren's syndrome

Special Care in Dentistry

Volumn 30, Issue 6, 2010, Pages 225-229

  Singh, Medha ^a   Stark, Paul C ^a   Palmer, Carole A ^a   Gilbard, Jeffrey P ^b   Papas, Athena S ^a  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

dry mouth; omega 3 fatty acids (n 3); probing depth; saliva secretion; Sj gren's syndrome

Indexed keywords

ALPHA TOCOPHEROL; OMEGA 3 FATTY ACID; VEGETABLE OIL; WHEAT GERM OIL;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SJOEGREN SYNDROME; TREATMENT OUTCOME; XEROSTOMIA;

AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLANT OILS; PROSPECTIVE STUDIES; SALIVATION; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VITAMIN E; XEROSTOMIA;

EID: 78649314165     PISSN: 02751879     EISSN: 17544505     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2010.00158.x     Document Type: Article

References (17)

1. Fox RI, Stern M, and, Michelson P,. Update in Sjögren syndrome. Curr Opin Rheumatol 2000; 12: 391 - 8.
2. Website: Sjögren's Syndrome Foundation. Accessed July 2007.
3. Brennan M, Fox P, eds., Singh M, Contributing author. Clinician's Guide: Salivary Gland and Chemosensory Disorders, 1st ed. Edmonds, WA: American Academy of Oral Medicine; 2009.
4. Singh M, Palmer C, Papas A,. Sjögren's Syndrome: Dental Considerations. Dentistry Today 2010; 29 (5):64, 66 - 7.
5. Sullivan BD., Cermak JM., Sullivan RM, et al. Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjögren's syndrome. Adv Exp Med Biol 2002; 506 (Pt A): 441 - 7.
6. Oxholm P, Asmussen K, Wiik A, Horrobin DF,. Essential fatty acid status in cell membranes and plasma of patients with primary Sjögren's syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 239 - 45.
7. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA,. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005; 82: 887 - 93.
8. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554 - 8.
9. Pennington J, Spungen J,. Bowes and Church's food values of portions commonly used, 19th ed. Baltimore: Lippincott Williams & Wilkins; 2010: 311 - 4.
10. Medline Plus. Accessed March 2010.
11. Saito I, Terauchi K, Shimuta M, et al. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjögren's syndrome. J Clin Lab Anal 1993; 7: 180 - 7.
12. Fox RI, Kang HI, Ando D, Abrams J, Pisa E,. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152: 5532 - 9.
13. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B,. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000; 275: 721 - 4.
14. Wu D, Han SN, Meydani M, Meydani SN,. Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N Y Acad Sci 2004; 1031: 422 - 4.
15. Alexander JW,. Immunonutrition: the role of omega-3 fatty acids. Nutrition 1998; 14: 627 - 33.
16. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G,. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003; 18: 1206 - 16.
17. Kesavalu L, Bakthavatchalu V, Rahman MM, et al. Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease. Oral Microbiol Immunol 2007; 22: 232 - 9.